Albert Luderer - 30 Jun 2020 Form 4/A - Amendment Insider Report for Bionano Genomics, Inc. (BNGO)

Role
Director
Signature
/s/ R. Erik Holmlin, Attorney-in-Fact
Issuer symbol
BNGO
Transactions as of
30 Jun 2020
Transactions value $
$0
Form type
4/A - Amendment
Filing time
18 Jul 2022, 19:29:11 UTC
Date Of Original Report
02 Jul 2020
Next filing
14 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNGO Stock Option (Right to Buy) Award $0 +44.5K $0.00 44.5K 30 Jun 2020 Common Stock 44.5K $0.51 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in equal monthly installments over a one year period such that the option is fully vested on June 30, 2021, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan).
F2 The acquisition of the reported option was reported in a Form 4 filed on July 2, 2020, which mistakenly reported the expiration date as 06/30/2029.